A new study finds that people who quit weight-loss medications including GLP-1s regain weight four times faster than people who stop dieting or exercise

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth providers. The Food and Drug Administration recently approved an oral GLP-1 medication for the treatment of obesity and weight management.

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments that have reshaped the obesity

The medication, available at a lower cost, is an alternative to injections and increases accessibility for patients, some doctors say.

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while tackling coverage & adherence challenges.

A major study finds that weight loss drugs work while used, but weight and health benefits often return after stopping treatment.

How to lose weight in 2026 with the new Wegovy pill. Also in this month’s Your Health column: Is the super flu a real thing; and accessing mental health help in several languages.